|Home | About | Journals | Submit | Contact Us | Français|
Pulmonary neuroendocrine cells (PNECs) are the first cell type to differentiate within the primitive airway epithelium, suggesting a possible role in lung development. The differentiation of PNECs in fetal lung is governed by proneural genes such as the mammalian homolog of the achaete–scute complex (Mash-1) and a related transcription factor, hairy and enhancer of split1 (Hes-1). We examined the expression of Mash-1 and a downstream transcription factor Prox-1 in the developing mouse lung of wild-type and respective knockout mouse models. During early stages (embryonic day 12, E12) of development, only some PNECs expressed Mash-1 and Prox-1, but by E15, all PNECs coexpressed both transcription factors. PNECs failed to develop in Mash-1 but not in Prox-1-null mice, indicating that Mash-1 is essential for the initiation of the PNEC phenotype, whereas Prox-1 is associated with the development of this phenotype. As lung develops within a low O2 environment (fetal euoxia, pO2 ~20 to 30 mm Hg), we examined the effects of hypoxia on PNEC differentiation. Organ cultures of fetal mouse lungs at E12 and E16 were maintained under either 20% O2 (normoxia, Nox) or 5% O2 (hypoxia, Hox) and were examined every 24 h for up to 6 days in culture. In E12 explants, Hox enhanced branching morphogenesis and increased cell proliferation, but PNEC numbers and Mash-1 expression were significantly reduced. This effect could be reversed by switching the explants back to Nox. In contrast, Hox had no apparent effect on Hes-1 expression. Similarly, Hox had no effect on airway branching, PNEC numbers, or Mash-1 expression in E16 explants, indicating locked-in developmental programming. We suggest that during early stages of lung development, pO2 concentration in concert with neurogenic gene expression modulates PNEC phenotype. Thus, disturbances in intrauterine pO2 homeostasis could alter the functional maturation of the PNEC system and hence be involved in the pathogenesis of various perinatal pulmonary disorders.
Early stages of lung development are characterized by a continuously branching epithelial tubular system that grows and bifurcates in concert with a surrounding mesenchyme and an expanding vascular supply. However, during the course of lung branching morphogenesis, more that 40 cell types are eventually differentiated, whereas segmentation into trachea, proximal, and distal airways results in a highly specialized organ with complex functions. Within the developing lung, solitary pulmonary neuroendocrine cells (PNECs) are the first cells to differentiate within the primitive airway epithelium, whereas innervated clusters of PNECs forming neuroepithelial bodies (NEBs) develop by mid-gestation.1 PNEC/NEB may have an important role during lung morphogenesis, as these cells secrete a variety of potent bioactive substances, including serotonin or 5HT, and neuropeptides such as gastrin-releasing peptide (GRP) and calcitonin gene-related peptide (CGRP), which act as local mitogens affecting lung growth and differentiation.2,3 The numbers of PNEC/NEB increase toward birth, reaching a peak during the neonatal period.1,4 In late fetal and neonatal lung, NEB cells have been shown to express a membrane-delimited O2-sensing molecular complex that is activated by hypoxia, leading to the release of 5HT and neuropeptides, suggesting a function as airway oxygen sensors that are important during neonatal adaptation.5–7
It is also becoming clear that the lung develops within a hypoxic intrauterine environment (fetal pO2 of 20–30 mm Hg) and that fetal hypoxia is being increasingly recognized as an important element for intrauterine development. In particular, organogenesis of the kidneys8 and cardiovascular system9 is dependent on a low-oxygen environment. Recently, hypoxia was shown to increase branching morphogenesis in fetal lung explants.10 However, the role of hypoxia in the development and differentiation of PNEC/NEB cells has not been previously investigated.
The molecular mechanisms underlying PNEC/NEB development are only partially known. The mammalian homolog of the proneural gene of the Drosophila achaete–scute complex, Mash-1, which encodes a basic helix–loop–helix (bHLH)-type transcription factor, has been identified as a key regulatory gene in PNEC development, as Mash-1 knockout mice have no detectable PNECs.11,12 Prox-1 (related to the Drosophila homeobox gene, prospero) is involved in the development of taste buds, lens, and the CNS.13–15 Both Mash-1 and Prox-1 are defined as molecular markers for transient precursors in the CNS.15 Prox-1 regulates the exit of progenitor cells from the cell cycle.14 A more recent study of pre- and postnatal mouse brain showed that Prox-1 was initially expressed in subventricular and early differentiating regions of the brain but was then restricted to the hippocampus and the cerebellum during adulthood, indicating a differential requirement.16 The expression of proneural transcription factors Mash-1 and Prox-1 in the nervous system is thus transient and precedes neuronal differentiation. As these two transcription factors are closely associated during development, we investigated the temporal expression of Mash-1 in developing mouse fetal lungs and, along with Prox-1, in early to mid-fetal lung explants, representing two distinct phases in lung development. Furthermore we examined the role of hypoxia on PNEC/NEB differentiation at different stages of the developing lung.
In this study, we show that, whereas Mash-1 specifies initiation of PNEC/NEB differentiation, Prox-1 expression is downstream of Mash-1 and correlates with PNEC/NEB maturation but is not required for NEB morphogenesis. We also show that hypoxia has a critical role in the temporal expression of the PNEC/NEB phenotype. Thus, lung development seems to be orchestrated by gene–environment interactions in which key proneural transcription factors, in concert with oxygenation, pace lung development and phenotypic maturation of airway epithelial cells. The potential significance of our findings in terms of relevance to human disease, especially perinatal lung disorders characterized by PNEC/NEB cell hyperplasia, is discussed.
The animal study protocol was approved by the Animal Research Committee at Hospital for Sick Children. Timed-pregnant female C57Bl6 mice were killed at the E12 or E15 stage and their embryos were removed. Plug date was considered day 0 of pregnancy. Lung buds were removed from the embryos in a CO2-independent medium (Gibco, Burlington, ON, Canada) supplemented with penicillin/streptomycin, and these were transferred to porous membranes (cell culture insert, 8 μm pore size, 25 mm diameter; Becton Dickinson Labware, Oakville, ON, Canada) and incubated in six-well culture plates (Becton Dickinson Labware). Three to four explants per membrane were positioned in a well-separated arrangement and cultured at the air-medium interface in a chemically defined medium BGjb (Gibco) containing penicillin/streptomycin (Gibco). The experimental times and conditions used in these studies are shown in Figure 1. Cultures were incubated under 20% O2/5% CO2 or 5%O2/5% CO2 at 37 °C for up to 6 days. Half of the culture medium was changed on the third day. In another set of experiments, explants were first exposed to Hox for 6 days and then switched back to Nox for 24 h (reoxygenation). Control cultures were incubated for the same time period in normoxic conditions. Explants were viewed under phase microscopy with the images being captured using a Nikon digital camera and their layout arranged using Photoshop 7.0.
Pregnant Prox-1 (+/−) mice were provided by Dr G Oliver (St Jude's Children's Research Hospital, Memphis, TN, USA) and because of factors such as transport and timing, only E13 lung explants could be established in culture; however, E12 and E12 lungs were equivalent in terms of PNEC/NEB development. E13 lungs were placed into organ culture as described above for 2 days in normoxic conditions and then harvested for immunofluorescent staining. E13 organs are still considered ‘early fetal’ and culturing these E13 organs for 2 days was sufficient time to observe neuroendocrine differentiation and allowed us to immunostain for the developmental onset of CGRP (E15 in vivo). Livers from embryos were genotyped to determine wild-type or homozygous Prox1. Blocks of formalin-fixed paraffin-embedded lung tissue from Mash-1(−/−) mouse lung tissues were provided by Dr T Ito (Tokyo, Japan).
Branching morphogenesis was quantified under phase microscopy (Olympus BX60) and RSI image software (V.8.0), by counting the number of terminal branches present in explants cultured under normoxic and hypoxic conditions every 24 h over a 6-day period. Results were obtained from seven different pregnancies (n = 7); means ± s.e. values were calculated and significance was determined by t-test (criterion for significance, P < 0.05).
Whole-lung E12 organ cultures were maintained for 6 days. Explants were incubated with 10 μM BrdU for 90 min at 37°C for both Nox and Hox conditions. The labeling medium was then removed and fresh medium was added to the tissue for 20 min. The tissue was fixed in zinc formalin (Newcomer Supply, Middletown, WI, USA), washed with PBS, and embedded in O.C.T. (Sakura, Torrance, CA, USA) for frozen sections. Sections were sequentially incubated with 0.05% trypsin for 20 min, followed by 4 M HCl for 15 min at room temperature and then overnight with Mouse on Mouse reagents (Molecular Probes, Eugene, OR, USA) to block nonspecific binding. Subsequently, the sections were incubated with 10% normal donkey serum for 30 min at 37°C to further block nonspecific antibody binding. Anti-BrdU conjugated with Texas Red (Roche, Laval, QC, Canada) was then added for 45 min and sections were washed with PBS. DAPI (1:10 000) staining was applied to visualize nuclei. BrdU-labeled cells, indicating S-phase, in organ cultures from Nox and Hox conditions were quantified from four consecutive whole-lung sections from each explant (BrdU + / DAPI +, both magnification of × 100). Sections were mounted in an antifade medium (Vector Laboratories, Burlingam, CA, USA) and visualized using a fluorescence microscope (Olympus BX60) and RSI image software (V.8.0). Data were analyzed using Sigma Plot to generate figures. Results were obtained from four different pregnancies (n = 4) and s.e.m. and a t-test (significance if P < 0.05) were used to compare positive BrdU-labeled cells in whole-lung sections (mesenchyme plus airway epithelial) in both Nox and Hox cultures and normalized to DAPI + cells.
Lung buds were dissected from E12 to E15 and fixed in either zinc formalin or Bouins' fixative. After fixation, the tissue was dehydrated through a series of alcohols and embedded in paraffin for immunohistochemistry or snap frozen for immunofluorescence. Organ cultures were processed in a similar manner. Sections (5 μm) were deparaffinized and rehydrated through descending alcohol series and in PBS. For antigen retrieval, we used 10 mM sodium citrate buffer (pH 6.0; Sigma) and endogenous peroxidase quenched with 0.03% hydrogen peroxide (Fischer) in PBS for 10 min. After blocking nonspecific binding with 10% secondary species serum, the following primary antibodies and dilutions were used: monoclonals for PGP9.5 (1:400; Ultraclone Ltd., White, England), Mash-1 (1:20; Becton-Dickinson, Oakville, ON, Canada), SV2 (1:100; Iowa Developmental Studies Hybridoma Bank, University of Iowa, Iowa City, IA, USA), and polyclonals for Hes-1 (1:400; gift from Dr T Sudo, Toray Industries, Japan), CGRP (1:400; Chemicon, Temecula, CA, USA), and Prox-1 (1:400; Chemicon). Antibody against CC10 protein (pAb rabbit IgG from Santa Cruz Biotechnology at 1:400 dilution) was used as a marker for Clara cells. For mouse monoclonal antibodies, a Mouse on Mouse blocker (Vector Laboratories) was added to the serum step to reduce nonspecific binding. Specific immunoreactivities were detected using the avidin–biotin complex method (Vectastain ABC kit; Vector Laboratories) and biotinylated secondary antibody, followed by avidin-Texas Red (Jackson Laboratories, West Grove, PA, USA), as previously reported.17 Peroxidase was visualized with DAB chromogen (Invitrogen, Burlington, ON, Canada) and counterstained with hematoxylin. As a negative control, the primary antibody was omitted. For immunofluorescence, tissue was fixed in a solution of zinc formalin and frozen sections were prepared. Visualization of PGP9.5, CGRP, and SV2 was carried out using an indirect immunofluorescence method using either FITC- and Texas Red-conjugated secondary antibodies. Omission of the primary antibody did not show labeling above background levels in the lung airway epithelium. Immunofluorescence-labeled tissues were analyzed using confocal microscopy as previously described17 or an Olympus Microscope BX60, and were visualized with RSI image software (V.8.0).
Cell lysates were prepared from individual E13 fetal livers and from the liver of the heterozygous mother. For PCR amplification, we used 50 μl of buffer containing each dNTP at 50 mM, 6 pmol of each primer, 50 mM Tris-HCl (pH 8.5), 1.5 mM MgCl2, 20 mM (NH4)2SO4, 10% dimethyl sulfoxide, and 0.2 U of Taq polymerase. Initial denaturation was for 3 min at a temperature of 94°C, followed by 35 cycles. Annealing was set for 45 s at 60°C, followed by 45 s of polymerization at 72°C and denaturation for 45 s at 94°C. The cycle was repeated 35 times. The primer sequence used was Wt Fwd: 5′-ATCGCTTATGTGATGAGCACC-3′; Wt Rev: CC GAGTCCTGGGCCCGTGCAT-3′; and Mut Fwd: 5′-GAAGC GGGAAGGGACTGGCTGCTA-3′; Mut Rev: CGGGAGCGG CGATACCGTAAAGC-3′.
For all mouse tissues, ~ 5 mg of tissues for each sample was sonicated in TRIzol solution (Invitrogen, Carlsbad, CA, USA), homogenized by ultrasonicator, and applied to RNA purification columns according to the manufacturer's instructions (SupperArray, Frederick, MD). After washing the columns, the bound RNA was treated with DNAse I, washed, and eluted. A volume of 200 ng of total RNA (from each tissue sample) was reverse transcribed with RT annealing mixture in an iScript Select cDNA Synthesis Kit (Bio-Rad, Hercules, CA) and PCR was performed. The primer pairs used were Mash1: Fwd, 5′-AATGGACTTTGGAAGCAGGA-3′; and Rev, 5′-TTAGGTTCAGACACCAGTCAC-3′; Hes1: Fwd, 5′-CACAGAAAGTCATCAAAGCC-3′ and Rev, 5′-TGCTTCACAGTCATTTCCAG-3′. Controls included mouse E18 brain, which expresses abundant Mash1 mRNA, and mouse E18 liver, which is negative for Mash1 and positive for Hes1. For normalization of total RNA, a primer pair representing mouse β-actin (Clontech, Palo Alto, CA, USA) was included in the same reactions. Amplified products and DNA molecular weight markers (100 bp DNA Ladder; Invitrogen) were separated by electrophoresis in 2% agarose gels.
For nuclear protein preparation, lungs from different developmental stages (embryonic and newborn mouse) and lung explant cultures from various experiments were dissociated with strong vortexing in a hypotonic HEPES solution with 1 × protease inhibitor cocktail (Pierce). Lysates were centrifuged at 1000 g for 10 min at 4°C to remove the supernatant containing cell membranes and soluble cytoplasm proteins, and nuclear pellets were resuspended in RIPA solution and sonicated on ice with 1 × protease inhibitor cocktail. Protein concentrations were measured using the DC-Bio-Red protein detection kit (Bio-Rad Laboratories, Hercules, CA, USA).
For immunoprecipitation and western blots, 200 μg of each protein sample was coimmunoprecipitated with either Mash-1/β-tubulin or Hes-1/β-tubulin antibodies using the Seize X Protein G Immunoprecipitation Kit from Pierce(Thermo Fisher Scientific, Rockford, IL, USA), following the manufacturer's instructions. A volume of 20 μl of samples was mixed with 2 × sample buffer. After boiling at 100°C for 5 min, 30 μl/lane of the precipitated nuclear protein solution and 10 μl of Odyssey Fluo-protein marker (Li-COR, Lincoln, NE, USA) were electrophoresed in a 10% SDS-PAGE with 3% stacking gel and then electroblotted onto PVDF membranes using a Bio-Rad Mini-Gel Transfer system. After blocking with 4% BSA + 1% skim milk, membranes were processed through overnight coincubations with mouse monoclonal anti-Mash-1 and mouse anti-β-tubulin antibodies or with rabbit anti-Hes-1 and mouse anti-β-tubulin antibodies at 4°C. After washing in TBS-Tween 20, membranes were incubated for 1 h at room temperature in Qdot Secondary Antibody Conjugates (Qdot705 goat anti-mouse IgG (red)) that were diluted at 1:1000 in blocking buffer. After final washing in TBS-Tween 20, membranes were analyzed immediately using the Image Station 2000MM system with Filtered Epi Illumination (KODAK 415/100 bp) and images were captured using a CCD camera. Band densities within the linear range were analyzed with NIH Image J software. Values were obtained for individual samples (three separate scans performed in duplicate) and normalized to the mean values of β-tubulin used as housekeeping protein on the same blot with the same exposure time. Mean and s.e. values were calculated for each lane (n = 3). The nonparametric, unpaired t-test was used for comparison between the two groups with Prism GraphPad version 5.01 software (GraphPad Prism Software).
Analysis of PGP9.5-positive PNECs per mm2 tissue was carried out by manually counting individual PNECs per section (minimum of four sections/lung) as normalized to the individual lung bud area using an Olympus microscope and SimplePCI software on acquired digital images. As it was difficult to discriminate different lung areas in explants, PNECs were enumerated per total explant area. The information displayed in each graph represents total counts and comprised different numbers of lungs (n values) and pregnancies. For Figure 4g and h, data were obtained from n = 7 and n = 4, and seven and four different pregnancies, respectively. For Figure 5, data were obtained from n = 5 and five different pregnancies. Standard error of the mean with a P < 0.05 (t-test) was used to determine the level of significance.
Immunolabeling for Mash-1 and Prox-1 was individually performed on paraffin sections of lung from mice at E12, E13, E14, and E15 stages of development. Both Mash-1 and Prox-1 immunoreactivity was localized to the nuclei of single or clusters of primitive airway epithelial cells distributed along the basement membrane (Figure 2a–h). Often Mash-1- and Prox-1-positive cells were arranged in rows, especially at airway branch points, the preferential location for NEB in mature lungs (Figures 1f and and2b).2b). In general, most cells expressing Mash-1 at E12 and E13 were negative for Prox-1 (Figure 2b versus f); however, in some areas, there was coexpression of Mash-1 and Prox-1 in nascent NEB (Figure 2a versus e, and b versus f). In comparison, by E15, all Mash-1-positive cells also became Prox-1 positive (Figures 1h and and2d).2d). For colocalization of both Mash-1 and Prox-1 in the same lung sections, we used double immunofluorescence labeling and confocal microscopy (Figure 2i–l). Between E12 and E14, about half of the Mash-1-positive cells were also Prox-1 immunoreactive, whereas at E15, all Mash-1-positive cells expressed Prox-1 (Figure 2j–l). Morphometric analysis showed a progressive and nearly linear increase in Mash-1 and Prox-1 coexpressing cells from about 60% at E12 to 100% by E15. The results of these studies are summarized in Figure 1.
The development and maturation of PNEC/NEB cells in the lung occurs in a proximal to distal direction.18 Consequently, PNEC/NEB cells develop first in the proximal better-differentiated airways, whereas in more peripheral primitive tubules, the immature pulmonary epithelium lacks PNEC/NEB and seems diffusely PGP9.5 positive.19 We therefore examined the coexpression of PGP9.5, a neuroendocrine marker, with Mash-1 and Prox-1 using double immunofluorescence labeling. At the E14 stage of development, in the larger more proximal airways, single and small clusters of Mash-1-positive cells were PGP9.5 positive, and well-defined NEB coexpressed Prox-1 (Figure 2m and n). In comparison, in the small, undifferentiated airways, both epithelium and PNECs were PGP9.5 positive (see Figure 3a). At E15, all Mash-1-positive cells were Prox-1 and PGP9.5 positive, including nascent submucosal nerve fibers innervating NEB (Figure 2o and p). Thus, E15 is seen as an important developmental transition point for acquisition of the neuroendocrine phenotype. Taken together, immunolabeling studies indicate that Mash-1 expression precedes Prox-1 and PGP9.5 expression in PNEC/NEB cells (Figure 1).
The findings of developmental regulation of Mash-1 expression observed by immunohistochemistry were confirmed by western blot analysis (Figure 2q) and RT-PCR (Figure 2r) of lung tissue extracts from fetal stages of E12–E18 and postnatally at day 4 (P4). Developmental expression of Mash-1 that peaked at E15 correlated well with the immunolabeling findings. In contrast, Hes-1 expression, a marker of the nonneuroendocrine respiratory epithelium, did not change throughout fetal lung development, again correlating with the immunolabeling observations (Figure 2q and r). An apparent increase in Hes-1 at P4 is suggestive of respiratory epithelial maturation.
To further explore the roles of Mash-1 and Prox-1 in PNEC/NEB development, we examined mutant mouse strains in which Mash-1 and Prox-1 expressions were genetically disrupted. As expected, paraffin sections of lung from Mash-1 knockout (−/−) mice on P3 showed an absence of Mash-1-positive cells and lack of demonstrable PNEC/NEB, as determined by the absence of PGP9.5- and CGRP-expressing cells in the airway epithelium (data not shown). Serial sections immunostained for Prox-1 also showed an absence of Prox-1-positive cells, suggesting that expressions of these genes were linked. Conversely, we next studied PNEC/NEB in the lungs of Prox-1 mutant mice. As Prox-1(−/−) mice survive only until E14.5, we examined frozen sections of lung from these mice immunostained for Mash-1 and found cells within the airway epithelium that showed Mash-1-positive nuclei, but their cytoplasm was negative for PGP9.5 (Figure 3a and b). This finding suggests that Mash-1-committed undifferentiated PNEC/NEB cells are present in the lungs of Prox-1(−/−) mice. However, on first analysis, Prox-1 expression seemed to be linked to the development of the PNEC/NEB neuroendocrine phenotype, as these Mash-1-positive cells did not express PGP9.5. However, when lung explants from E13 Prox(−/−) lungs were maintained in culture for 2 days, we found Mash1-positive cells that expressed both PGP9.5 and CGRP, suggesting that PNEC maturation can proceed in the absence of Prox-1 as long as Mash-1 expression is maintained (Figure 3c–f). There was no significant difference in the number and frequency of PGP9.5-positive PNEC/NEB cells in the lungs of wild-type compared with Prox-1(−/−) mice.
To study the effects of hypoxia on lung development and PNEC/NEB differentiation, we used organ cultures of lung explants maintained on culture inserts and exposed either to normoxia (20% O2) or hypoxia (5% O2). E12 lung buds were explanted under normoxic and hypoxic conditions and peripheral branching (terminal ends) was assessed every 24 h over a 6-day period. Over a 6-day culture period, lung explants underwent exponential growth, and complexity of the distal airways became evident (Figure 4a, c and e). In agreement with previous reports,10 organ cultures exposed to hypoxia had significantly more terminal branches compared with parallel cultures grown in normoxic conditions10 (Figure 4b, d and f). A quantitative study of peripheral bud counts showed a significant increase in airway branching under hypoxia compared with normoxia (Figure 4g). Organ cultures exposed to hypoxia showed a higher proliferative index (~ 49%) compared with normoxia (~ 33%) using the BrdU labeling method (Figure 4h).
To examine the effects of hypoxia on PNEC/NEB differentiation, some E12 explants were maintained in hypoxia for 24 h (short-term hypoxia), and others for 6 days (long-term hypoxia), and then immunostained for PGP9.5 and SV2 (Figure 5) Control lung explants cultured under normoxia underwent extensive PNEC differentiation, as indicated by the presence of numerous PGP9.5- and SV2-positive PNEC/NEB cells and the development of large corpuscular NEB cells (Figure 5a and c). In contrast, lung explants maintained under hypoxia showed a markedly reduced expression of both PGP9.5- and SV2-positive cells in the airway epithelium (Figure 5b and d), although bronchial ganglion cells and nerves immunoreactive for PGP9.5 and SV2 were unaffected (data not shown). These effects of hypoxia seemed to be PNEC/NEB-cell-specific, as no changes were observed in the expression or frequency of CC10-positive epithelial cells corresponding to differentiating Clara cells (Figure 5e and f). Morphometric analysis showed more than a fivefold reduction in the number of PGP9.5 immunoreactive PNEC/NEB cells in explants maintained in hypoxia compared with control normoxia cultures (Figure 5g).
E12 explants exposed to hypoxia for 6 days showed a markedly reduced expression of Mash-1 compared with normoxia control (Figure 6a and b), whereas that of Hes-1, a marker for the nonneuroendocrine epithelium, was maintained (Figure 6c and d). Thus, the nonneuroendocrine airway epithelial cell component seemed to be unaffected by hypoxia. In lung samples taken after stage E15, PNEC/NEB cells became insensitive to hypoxia, as E16 lung explants cultured for 6 days under hypoxia retained a full expression of both Mash-1 and Hes-1, comparable to that of normoxia controls (Figures 1 and 6g–j).
It is evident from the data in Figure 1 that PNEC/NEB maturation is initiated at E15 and that, together with the in vitro observations, a critical mid-gestation switch occurs in the hypoxia-sensitive to hypoxia-insensitive developmental phase corresponding to maturation of PNEC/NEB cells after E15. These observations support the notion that E15 is a critical time point in PNEC/NEB development when they become refractory to the hypoxia stimulus.
As we found that hypoxia downregulated Mash-1 expression, we asked whether Mash-1 expression is possibly regulated through oxygenation. In these experiments, E13 explants were first placed under hypoxia for 1–6 days and then switched back to normoxia for a 24-h (1 day) period. As expected, in explants exposed to hypoxia (both short- and long term), Mash-1 expression was significantly reduced but became re-expressed strongly when lung explants were switched to normoxia (Figure 7a–h). Although in control lung explants maintained under normoxia PNEC/NEB cells showed positive CGRP immunoreactivity (Figure 7b), it was negative in the lung explants that were switched from hypoxia to normoxia (Figure 7d). In comparison, in the long-term cultures switched from hypoxia to normoxia (Figure 7h), expression of PGP9.5 was increased, coincident with a strong expression of Mash-1. These observations suggest that hypoxia can acutely regulate the differentiation of PNEC/NEB and thus pace this developmental process. In addition, as there was a more robust expression of Mash-1 after reoxygenation when lung explants were switched from hypoxia to normoxia, this observation suggested that pO2 concentration may be important for the expansion of Mash-1-committed PNEC progenitors in which Mash-1 expression precedes maturation markers such as CGRP and seems to coincide with the induction of PGP9.5 expression.
To provide quantitative assessment of the expression of Mash-1 and Hes-1 at the mRNA and protein level, respectively, we performed RT-PCR and western analysis of extracts from lung explants under different pO2 conditions. Owing to the relatively low numbers of PNEC/NEB cells in the lung (representing lt&;1% of lung epithelial cells), we used immunoprecipitation to concentrate Mash-1 protein and a highly sensitive detection system for western blot as described in Materials and Methods. As expected, in E12 lung explants maintained in hypoxia for 6 days, the expression of both Mash-1 mRNA and protein was significantly reduced, whereas Hes-1 expression was unaffected (Figure 8a and b). Again, when explants exposed to hypoxia were switched to normoxia for 24 h, there was a robust upregulation of Mash-1 mRNA and protein expression, supporting the notion that hypoxia has a regulatory role in Mash-1 expression and thereby PNEC/NEB development. Significantly, in E16 explant cultures, hypoxia had no effect on Mash-1 expression, in agreement with immunostaining data (Figure 8a and b), highlighting this critical developmental switch at E15.
The principal aim of this study was to investigate the role of neurogenic genes in the differentiation of PNEC/NEB cell lineage in the developing lung and to examine the effects of different pO2 concentrations on this process. Our studies (summarized in Figure 1) suggest that the bHLH-type transcription factor, Mash-1, and the homeodomain-containing protein, Prox-1, not only delineate a transient precursor of PNEC/NEB cells but also define the temporal limits between the process of initiation and maturation. Previous studies have identified Mash-1 as the obligatory transcription factor required for the development of PNEC/NEB, as Mash-1 −/− mouse lungs are devoid of these cells.12 In this study, we show that Mash-1 remains the earliest known expression marker specific to PNEC/NEB and that Prox-1 is involved in the subsequent specification of PNEC/NEB phenotypic maturation.
For NEB to become fully functional as airway sensors, they require extensive innervation, derived principally from the nodose ganglion.20 We postulate that Prox-1 may be involved in regulating the process of PNEC/NEB innervation. It has been shown recently that Prox-1 differentially regulates neuropilins, NRP1 and NRP2, involved in axonal guidance and angiogenesis.21 Mash-1/Prox-1-positive precursor cells are found throughout the CNS15 and PNS,22 and therefore coexpression of these two transcription factors seems to be a general phenomenon during the early stages of neural development. During later stages of development, Prox-1 expression becomes restricted to the hippocampus and cerebellar neurons.16 Other studies have linked Prox-1 to an involvement in the subsequent specification of other neural progeny15,23,24 in both the CNS and PNS.
Our RT-PCR and western blot analyses of a gestational series of lungs up to P4 clearly show that Mash-1 expression peaks at E15, correlating with the immunostaining for Mash-1, whereas Hes-1 expression is relatively constant throughout lung development, with an apparent increase postnatally. Upstream to Mash-1 are other members of the Notch family of neurogenic genes that delineate neuroendocrine vs nonneuroendocrine cell fates.25
In the lung, expression of ASCL1 (ASH-1) in humans and Ascl1 (Mash-1) in mice directs PNEC differentiation, whereas Hes-1 expression regulates the differentiation of nonneuroendocrine cells that also express the Notch1 receptor.25 Notch-1 is reduced in the lung epithelium of Hes-1-null(−/−) mice, whereas Mash-1 is increased.25 In Hes-1 (−/−) lungs, precocious development of PNEC is noted at E13, followed by PNEC hyperplasia by E18. Only a sub-population of airway cells differentiate into PNECs, whereas CC10-expressing cells predominate, suggesting that other factors determine lineage fate as well. Overexpression of Notch-1 in a transgenic mouse by targeting Notch-1 to PNECs through the calcitonin promoter induced a marked decrease in PNECs.26 Interestingly, expression of the mammalian Notch 1 ligand, Delta-like 1 (Dll 1), correlates with the appearance of PNECs,27 whereas Mash-1-deleted lungs also show loss of Dll 1.25 This suggests that Mash-1 may regulate Dll 1 expression and this may also affect the development of nonneuroendocrine cells, an interaction that is still unclear. Interestingly, knockdown of Notch-1 expression with antisense oligonucleotides in culture results in increased branching of embryonic lung buds,27 as seen here with hypoxia, although we did not observe a change in Hes-1 expression. In addition, as antisense to Notch-1 markedly increases the number of PNECs, it is conceivable that other factors of the ‘neural lateral inhibition’ pathway exist and are potentially functional in the lung.28
Our studies on the effects of hypoxia on PNEC/NEB cell differentiation in the developing lung clearly show that short-term (24 h) and sustained, long-term (6 days) hypoxia downregulates Mash-1 expression and leads to loss of the PNEC/NEB phenotype.
We also show that this sensitivity to hypoxia is restricted to early stages of lung development and that, on reoxygenation, Mash-1 expression can be restored. Although here we did not assess proliferation after reoxygenation, it is a consideration for future studies, as there was an apparent burst of Mash-1-positive clusters. Although we recognize that our data are derived from in vitro experimental models, it may simulate effects of intermittent hypoxia that are known to be a significant factor in a number of clinical settings.29. In other cell systems, hypoxia is known to downregulate the expression of neuronal/neuroendocrine marker genes and to induce neural crest sympathetic progenitors expressing Notch-130 and structural proteins such as nestin associated with the stem cell state.31 It can be inferred that Mash-1-positive cells represent an undifferentiated, but perhaps committed, neuroepithelial cell type and that low-oxygen tension maintains the undifferentiated state or, at least, does not allow progression of differentiation. Recent studies shed more light on the possible role of Notch and its relevance to PNEC/NEB and hypoxia. In non-small-cell lung carcinomas, hypoxia elevates Notch signaling and downstream Hes-1 expression,32 whereas inducing Notch expression in small-cell lung carcinoma (derived from PNEC) causes cell cycle arrest.33 Interestingly, in human embryonic stem cells that are in continuous hypoxia, similar to 5% O2 used here, Notch activation is maintained and spontaneous differentiation is suppressed, with differentiation rapidly resuming after a switch to normoxia.34 Thus, evidence from different embryonic lineages strongly supports the idea that hypoxia keeps progenitors in a more undifferentiated state, which is reversible on increasing oxygenation. Given the idea of cell context-dependent regulatory mechanisms and outcomes, our observations support a central role for hypoxia in the regulation of PNEC/NEB development. Whether this is relevant for PNEC pathobiology still needs to be determined.35
Our findings on western blot and RT-PCR analyses of lung organ cultures suggest that hypoxia modulates Mash-1 expression in the lung, but the precise mechanism is unknown. Hypoxia-inducible factors (HIFs) are known to be intimately involved in cell and tissue responses to pO2.36 HIFs (HIF1–3) are differentially expressed in different cell compartments during lung development,37 whereas differentiation of alveolar epithelium requires HIF-1a, likely through regulation of angiogenesis.38 Whether HIF regulates the development of PNEC/NEB is yet to be explored.
Taken together, the data present a developmental scenario as follows: During early fetal lung development, Mash-1-positive cells start to appear within primitive undifferentiated lung epithelial cells, resembling a primitive neuroepithelium. Although a low-oxygen environment (5% O2) stimulates pulmonary epithelial branching morphogenesis, it retards PNEC/NEB differentiation but seems to amplify putative PNEC progenitors. Increased epithelial branching is accompanied by increased cell proliferation as shown by BrdU labeling. Van Tuyl et al10 explored the effects of hypoxia using a similar in vitro model and found that epithelial differentiation was maintained at low oxygen as determined by surfactant protein C expression. The fact that a fine balance in oxygenation is likely to be obligatory for normal lung development is shown by the fact that hyperoxia has an opposite effect by significantly reducing branching and by inducing apoptosis.39 PNEC/NEB commitment is then driven by Mash-1 and maintained under increasing pO2 (toward normoxia) until E15, at which point, Mash-1 regulation becomes pO2 independent. Thus, E15 seems to be the critical transition point in mouse lung development for maturation of the PNEC/NEB lineage. We therefore predict the existence of a similar critical pO2-dependent gestational threshold in other species.
Finally, the findings reported here could provide important clues to the pathogenesis of several pediatric lung disorders, as well other areas of human pathobiology.
Hyperplasia of PNEC/NEB cells has been described in various developmental and perinatal lung disorders, including pulmonary hypoplasia, bronchopulmonary dysplasia (BPD), sudden infant death syndrome (SIDS), and others, but the significance and mechanisms are unknown.40 Of particular interest is the so-called ‘post surfactant’ BPD that occurs in extremely premature infants and is characterized by arrested alveolar development, thickened interalveolar septae, and striking hyperplasia of bombesin/GRP immunoreactive PNEC/NEB in the airways.40 It is conceivable that the birth of an extremely premature infant (accustomed to relative intrauterine hypoxic environment) exposes the lungs to higher atmospheric O2 concentration (normoxia), mimicking our in vitro reoxygenation experimental model. In this setting, increased ASH-1 (human homolog of Mash-1) expression could account for PNEC/NEB hyperplasia and, through the effects of increased bombesin/GRP secretion, could lead to interstitial fibrosis and alveolar growth abnormalities.41 In the case of SIDS, combined effects of intrauterine intermittent hypoxia and nicotine (in infants whose mothers smoked during pregnancy) could account for NEB cell hyperplasia with a defective chemoreceptor function.42 It is also plausible that intrauterine hypoxia/reoxygenation affects the expression of Mash-1 in other organs including the developing CNS and could hence be involved in the pathogenesis of various perinatal neurological disorders. Further studies are clearly indicated to answer these and related questions.
The authors greatly appreciate the generosity of Dr T Ito (Tokyo) for providing Mash-1 −/− tissues, Dr G Oliver for Prox1 −/− tissues, and Dr T Sudo (Toray Industries, Japan) for the Hes-1 antibody. We thank Catherine Luk (Hospital for Sick Children) for helpful assistance with genotyping Prox-1 tissue, and Robert Qaqish and Bikul Das (Hospital for Sick Children) for helpful assistance with selection of PCR primers and western blotting, respectively. This study was supported by Canadian Institutes of Health Research grants: #MOP-12742, MGP 15270 to EC and HY.